Yanan Xu
ORCID: 0000-0002-0091-9709
· 4 papers in corpus
lab-animal
2026
OBJECTIVE: Currently, surgical intervention is the primary treatment for endometriosis (EM), but recurrence is common. This study aims to identify novel potential therapeutic targets for effective management of EM by investigating the role …
lab-animal
2024
OBJECTIVE: Abnormal expression of circular RNA (circRNA) leads to the occurrence and development of endometriosis (EM), but its underlying mechanisms are largely unknown. METHODS: Abnormally expressed circRNAs were screened in EM and norma…
other
2024
AIMS: Endometriosis is characterized by an abnormal immune microenvironment. Despite the extensive use of immune therapies, the application of immune checkpoint inhibitors in endometriosis lacks confidence due to the instability of preclini…
lab-animal
2022
LncRNAs are involved in the pathophysiologic processes of multiple diseases, but little is known about their functions in hepatic ischemia/reperfusion injury (HIRI). As a novel lncRNA, the pathogenetic significance of hepatic nuclear factor…